Free Trial

Weiss Ratings Reaffirms "Sell (E+)" Rating for Research Frontiers (NASDAQ:REFR)

Research Frontiers logo with Computer and Technology background

Key Points

  • Weiss Ratings has reaffirmed a "sell (E+)" rating for Research Frontiers (NASDAQ: REFR), indicating potential concerns about the company's performance.
  • Research Frontiers reported earnings of ($0.02) per share for its last quarter, with a revenue of only $0.13 million and a negative net margin of 143.78%.
  • A hedge fund, Raymond James Financial Inc., significantly increased its stake in Research Frontiers by 151.5%, now owning 41,337 shares valued at approximately $68,000.
  • Five stocks we like better than Research Frontiers.

Research Frontiers (NASDAQ:REFR - Get Free Report)'s stock had its "sell (e+)" rating reissued by research analysts at Weiss Ratings in a research report issued on Tuesday,Weiss Ratings reports.

Research Frontiers Stock Performance

Shares of Research Frontiers stock traded up $0.05 on Tuesday, reaching $1.87. 112,261 shares of the stock were exchanged, compared to its average volume of 37,050. The firm's 50 day moving average is $1.47 and its 200-day moving average is $1.49. Research Frontiers has a one year low of $0.93 and a one year high of $2.31. The firm has a market cap of $62.79 million, a PE ratio of -37.90 and a beta of 0.34.

Research Frontiers (NASDAQ:REFR - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The technology company reported ($0.02) earnings per share for the quarter. The business had revenue of $0.13 million during the quarter. Research Frontiers had a negative net margin of 143.78% and a negative return on equity of 72.81%.

Institutional Investors Weigh In On Research Frontiers

A hedge fund recently raised its stake in Research Frontiers stock. Raymond James Financial Inc. raised its position in Research Frontiers Incorporated (NASDAQ:REFR - Free Report) by 151.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 41,337 shares of the technology company's stock after purchasing an additional 24,902 shares during the quarter. Raymond James Financial Inc. owned 0.12% of Research Frontiers worth $68,000 as of its most recent SEC filing. Institutional investors and hedge funds own 11.91% of the company's stock.

About Research Frontiers

(Get Free Report)

Research Frontiers Incorporated engages in the development and marketing of technology and devices to control the flow of light worldwide. It develops and licenses suspended particle device (SPD-Smart) light-control technology to companies that manufacture and market the SPD-Smart chemical emulsion, light-control film made from the chemical emulsion, the light-control panels made by laminating the film, and electronics to power end-products incorporating the film, as well as lamination services for and the end-products, such as windows, skylights, and sunroofs.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Research Frontiers Right Now?

Before you consider Research Frontiers, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Research Frontiers wasn't on the list.

While Research Frontiers currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.